Preliminary work utilizing cell-based therapy has demonstrated that mesenchymal stem cells (MSCs) transfected with Ang1 are able to engraft the pulmonary endothelium damaged during sepsis, preserve pulmonary endothelial integrity, and ameliorate ALI/ARDS (206, 207). The gene discussed is ANGPT1; the disease is Sepsis.